Literature DB >> 2114209

Hypercalcemic hyperparathyroidism and hypophosphatemic osteomalacia complicating neurofibromatosis.

R S Weinstein1, R L Harris.   

Abstract

Neurofibromatosis is sometimes complicated by impaired renal tubular reabsorption of phosphate, hypophosphatemia, and osteomalacia. Hyperparathyroidism has also been reported in patients with neurofibromatosis. When hypercalcemia and elevated levels of parathyroid hormone are found in osteomalacia, however, it may be difficult to determine if the hyperparathyroidism was primary or tertiary. We describe a patient with neurofibromatosis, hypercalcemic hyperparathyroidism, hypophosphatemic osteomalacia, vitamin D deficiency, and clear-cell hyperplasia of all four parathyroid glands. Serial biomechanical, bone biopsy, and densitometric studies confirmed that treatment with ergocalciferol, calcium, and phosphate supplements significantly improved the osteomalacia but caused increased parathyroid overactivity. After subtotal parathyroidectomy, the parathyroid hormone concentration became normal and the bone mineral content increased at the spine and hip, but inappropriate phosphaturia persisted. The findings indicate that hyperparathyroidism, osteomalacia, and vitamin D deficiency adversely affect each other.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2114209     DOI: 10.1007/bf02554965

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  30 in total

1.  Simultaneous occurrence of von Recklinghausen's neurofibromatosis and osteitis fibrosa cystica; report of a case showing both diseases in addition to liposarcoma.

Authors:  D H CLARK; W R MATHEWS
Journal:  Surgery       Date:  1953-03       Impact factor: 3.982

2.  Looser-Milkman's syndrome with neurofibromatosis Recklinghausen and general decalcification of the skeleton.

Authors:  C A HERNBERG; W EDGREN
Journal:  Acta Med Scand       Date:  1949-11-30

3.  Hypophosphatemic osteomalacia complicating von Recklinghausen's neurofibromatosis: increase in spinal density on treatment.

Authors:  D B Hogan; C Anderson; R A MacKenzie; R G Crilly
Journal:  Bone       Date:  1986       Impact factor: 4.398

Review 4.  Is the clinical expression of primary hyperparathyroidism a function of the long-term vitamin D status of the patient?

Authors:  C R Kleeman; K Norris; J W Coburn
Journal:  Miner Electrolyte Metab       Date:  1987

Review 5.  Von Recklinghausen neurofibromatosis.

Authors:  V M Riccardi
Journal:  N Engl J Med       Date:  1981-12-31       Impact factor: 91.245

6.  A new mechanism for induced vitamin D deficiency in calcium deprivation.

Authors:  M R Clements; L Johnson; D R Fraser
Journal:  Nature       Date:  1987 Jan 1-7       Impact factor: 49.962

7.  Tertiary hyperparathyroidism.

Authors:  D R Davies; C E Dent; L Watson
Journal:  Br Med J       Date:  1968-08-17

Review 8.  Hypercalcemic hyperparathyroidism complicating oncogenic osteomalacia. Effect of successful tumor resection on mineral homeostasis.

Authors:  I R Reid; S L Teitelbaum; A Dusso; M P Whyte
Journal:  Am J Med       Date:  1987-08       Impact factor: 4.965

9.  Neurofibromatosis with hypophosphatemic osteomalacia (Von Recklinghausen-Hernberg-Edgren-Swann syndrome) (a case report).

Authors:  V J Retnam; D M Rangnekar; S D Bhandarkar
Journal:  J Assoc Physicians India       Date:  1980-09

10.  Irreversible bone loss in osteomalacia. Comparison of radial photon absorptiometry with iliac bone histomorphometry during treatment.

Authors:  A M Parfitt; D S Rao; J Stanciu; A R Villanueva; M Kleerekoper; B Frame
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

View more
  6 in total

1.  High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1.

Authors:  S Seitz; C Schnabel; B Busse; H U Schmidt; F T Beil; R E Friedrich; T Schinke; V F Mautner; M Amling
Journal:  Osteoporos Int       Date:  2009-05-05       Impact factor: 4.507

2.  Subepidermal Calcified Nodule in a Child With Neurofibromatosis Type 1.

Authors:  Buket Bagci; Cansu Karakas; Murat Gokden
Journal:  Cureus       Date:  2022-03-17

3.  Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin.

Authors:  Mateusz Kolanczyk; Jirko Kühnisch; Nadine Kossler; Monika Osswald; Sabine Stumpp; Boris Thurisch; Uwe Kornak; Stefan Mundlos
Journal:  BMC Med       Date:  2008-07-31       Impact factor: 8.775

4.  Parathyroid adenoma and bilateral pheochromocytoma in a patient with neurofibromatosis.

Authors:  Basmah Al-Wahhabi
Journal:  Ann Saudi Med       Date:  2005 May-Jun       Impact factor: 1.526

5.  Hypophosphatemic osteomalacia in neurofibromatosis 1 associated with intracranial gliomas and congenital renal agenesis: A rare case report and review of the literature.

Authors:  Angelos Kaspiris; Elias Vasiliadis; Dimitra Melissaridou; Ilias D Iliopoulos; Panayiotis J Papagelopoulos; Olga D Savvidou
Journal:  J Orthop Case Rep       Date:  2022-02

Review 6.  Current Aspects on the Pathophysiology of Bone Metabolic Defects during Progression of Scoliosis in Neurofibromatosis Type 1.

Authors:  Angelos Kaspiris; Olga D Savvidou; Elias S Vasiliadis; Argyris C Hadjimichael; Dimitra Melissaridou; Stella Iliopoulou-Kosmadaki; Ilias D Iliopoulos; Evangelia Papadimitriou; Efstathios Chronopoulos
Journal:  J Clin Med       Date:  2022-01-15       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.